Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Rangering i aksjer #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Aksjekurs
$4.06
Sist synkronisert: 2024-02-23
Markedsverdi
$145.61M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Theseus Pharmaceuticals, Inc. (THRX)

Kategori

Aksjeprishistorikk for Theseus Pharmaceuticals, Inc. (THRX)
Høyeste sluttskurs: $4.07 den 2024-02-01

Laveste sluttskurs: $16.20 den 2021-10-01
Aksjeprishistorikk for Theseus Pharmaceuticals, Inc. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2024 5.46%
2023 -30.80%
2022 -54.19%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH